Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Medalist Diversified REIT A Pref | MDRRP | Nov 12, 2024 | 25.00 | -6.09 |
Medallion Bank F Pref | MBNKP | Nov 12, 2024 | 25.77 | +0.07 |
Medallion Financial | MFIN | Nov 12, 2024 | 9.62 | -2.93 |
MediaAlpha | MAX | Nov 12, 2024 | 12.47 | -1.89 |
Mediaco A | MDIA | Nov 12, 2024 | 1.14 | -5.00 |
Medical Properties Trust | MPW | Nov 12, 2024 | 4.35 | -3.97 |
MediciNova | MNOV | Nov 12, 2024 | 2.28 | +49.02 |
Medifast | MED | Nov 12, 2024 | 19.41 | -0.10 |
MEDIROM Healthcare Technologies ADR | MRM | Nov 12, 2024 | 2.64 | -2.65 |
MediWound | MDWD | Nov 12, 2024 | 16.91 | -2.76 |
Mednax | MD | Nov 12, 2024 | 15.50 | -2.88 |
Medpace | MEDP | Nov 12, 2024 | 360.81 | -0.76 |
Medtronic | MDT | Nov 12, 2024 | 88.30 | +0.03 |
Mega Matrix | MPU | Nov 12, 2024 | 1.59 | +0.63 |
Megacap 300 Growth Index ETF Vanguard | MGK | Nov 12, 2024 | 340.56 | +0.14 |
Megacap 300 Index ETF Vanguard | MGC | Nov 12, 2024 | 215.25 | -0.18 |
Megacap 300 Value Index ETF Vanguard | MGV | Nov 12, 2024 | 130.71 | -0.80 |
MEI Pharma | MEIP | Nov 12, 2024 | 3.14 | +0.32 |
Meihua International Medical Technologies | MHUA | Nov 12, 2024 | 0.50 | +1.98 |
MeiraGTx Holdings | MGTX | Nov 12, 2024 | 6.66 | -6.20 |
Meiwu Technology | WNW | Nov 12, 2024 | 0.78 | -1.66 |
Melar Acquisition I | MACI | Nov 12, 2024 | 10.01 | +0.01 |
Melar Acquisition I | MACIU | Nov 12, 2024 | 10.13 | 0.00 |
Melco Resorts & Entertainment ADR | MLCO | Nov 12, 2024 | 6.29 | -6.81 |
MercadoLibre | MELI | Nov 12, 2024 | 1 977.39 | +0.83 |
Mercantile Bank | MBWM | Nov 12, 2024 | 50.22 | -0.28 |
Mercer International | MERC | Nov 12, 2024 | 6.38 | -1.85 |
Merchants Bancorp | MBIN | Nov 12, 2024 | 40.81 | -0.46 |
Merchants Bancorp B | MBINO | Nov 12, 2024 | 25.32 | +0.04 |
Merchants Bancorp C Pref | MBINN | Nov 12, 2024 | 22.55 | +0.33 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.